Key points are not available for this paper at this time.
An uncomplicated, widely available, prophylactic regimen (COCOON DM) reduced the incidence of DAEIs with amivantamab-lazertinib and the impact of symptoms on QoL.
Cho et al. (Tue,) studied this question.